Click to log on patient portal

Research

CCP Invasive Service is a leading expert in invasive research. With a 20-year history of participating in invetigational trials, we can offer the most current treatments and technology to patients who suffer from coronary artery disease, peripheral vascular disease and cerebrovascular disease.

Research trials that have brought revolutionary changes, such as coated stents, carotid disease stents, abdominal aneurysm treatment, heart attack drug therapy are available to our patients because of our participation in interventional trials. participation in interventional trials.Patients have the advantage of minimally invasive cardiovascular treatment, no general anesthesia, and a shorter discharge and recovery. CCP Invasive is committed to providing our patients with the latest research trials and innovative approaches to their disease.



Currently available research trials are:
 DIRECT Direct myocardial revascularization
  Laser trial for Class III IV angina
 SAFER SVG extraction type catheter
 VORTEX For use in saphenous vein bypass interventions
 Iliac Stent IVT stent versus conventional treatment for iliac stenosis
 A to Z Chest pain patients who receive Aggrastat, Heparin, and ASA.
  Can have intervention immediately or Aggrastat must run for at least 12
  hours after intervention. Then patients are started on ZOCOR.
 Acute 2 Lovenox/TEE/Cardioversion
 Madit II AICD post MI with Ef<30%
 Target Trial Cath lab study, Double Blind use of Aggrastat and ReoPro
 ACS Multi-Link   5-year follow-up on patients who received ACS Multi-Link 3 years ago
 AVE GFX Stent   5-year follow-up for AVE GFX stents
 SUPORT Boston Scimed stents versus ACS stents
 CONSERVE IVT low-pressure stent versus Guidant stent
 LP Stent LP versus Guidant stent
 HERMES Renal stents
 SAPPHIRE High-risk randomized trial CEA vs. Stent with Distal Protection
 ARCHER Carotid stents in High Risk PTS Non-randomized
 CRUISE Integrilin with Enoxaparin
 PRESTO Prevention of Restenosis with Tranilast
 SIRIUS Drug-coated Stent to Prevent Restenosis
 LIMIT Brachytherapy to Prevent Restenosis
 SAPHIRE Carotid Stent with Filter to Prevent Embolization
 CREST NIH Sponsored Comparing CEA to Carotid Stent with Distal
  Protection � Low-risk patients
 VEGAS Evaluation of Angiojet for Saphenouse Vein Graft Disease
 LACI Excimer Laser for Critical Limb Ischemia
 ARCHER High-risk Non-randomized Carotid Stent with Distal Protection
 CARESS Randomized Carotid Stent Trial for Low-risk
 DELIVER Randomized Coated Stent Trial to Reduce Restenosis